TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31548151

Group type: EXPERIMENTAL
Intervention: blepharitis eyelid cleanser (OCuSOFT® Lid Scrub® PLUS foam)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: diluted baby shampoo (10% Johnson's® No More Tears ®)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: tea-tree based face wash (dr.organic®)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cooled boiled water (control)
Number of subjects: 48
Study: 28784054

Group type: COMPARATOR
Intervention: Oxytocin infusion according to low-dose standard protocol
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Sublingual Misoprostol 25 μg every 4 h
Number of subjects: 270
Study: 27409466

Group type: EXPERIMENTAL
Intervention: MI-OCT+ (Microscope-Integrated OCT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: MI-OCT- (without MI-OCT guidance)
Number of subjects: 14

Group type: COMPARATOR
Intervention: MI-OCT- (initially without MI-OCT guidance)
Number of subjects: 14
Study: 25173140

Group type: EXPERIMENTAL
Intervention: Chemoradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiation alone
Number of subjects: 0
Study: 23043888

Group type: EXPERIMENTAL
Intervention: riluzole treatment for 8 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: healthy subjects (control group)
Number of subjects: 14
Study: 20492632

Group type: EXPERIMENTAL
Intervention: PLA cell autografts
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 26
Study: 18234290

Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.67 mg/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 22
Study: 16827700

Group type: EXPERIMENTAL
Intervention: sulphadoxine/pyrimethamine (SP), administered up to four times during pregnancy
Number of subjects: 2688

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2688

Group type: EXPERIMENTAL
Intervention: sulphadoxine/pyrimethamine (SP)
Number of subjects: 2688

Group type: EXPERIMENTAL
Intervention: sulphadoxine/pyrimethamine (SP) among women who did not use a bednet
Number of subjects: 2688

Group type: COMPARATOR
Intervention: placebo among women who did not use a bednet
Number of subjects: 2688
Study: 14632864

Group type: EXPERIMENTAL
Intervention: Stented (stent left for 1 week)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Unstented (no stent)
Number of subjects: 64
Study: 10871145

Group type: EXPERIMENTAL
Intervention: Augmented LowDye tape
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Temporary felt orthotics
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 9083952

Group type: EXPERIMENTAL
Intervention: Diode laser photocoagulation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 19
Study: 8451010

Group type: EXPERIMENTAL
Intervention: Cabergoline (0.5 mg to 2.5 mg, taken once a day for 8 weeks)
Number of subjects: 25
Study: 3953366

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride (0.5 mg)
Number of subjects: 7
Study: 29887287

Group type: EXPERIMENTAL
Intervention: 600 mg oral CBD
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 10 mg oral THC
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 26848956

Group type: EXPERIMENTAL
Intervention: Stepping exercise at various heights and cadences (80, 90, 100, 110 steps-min-1; heights of 17, 25, 30, 34 cm)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Prescriptive equation for energy cost in METs
Number of subjects: 28
Study: 25146960

Group type: EXPERIMENTAL
Intervention: Education and counseling intervention to improve self-care in patients with HF
Number of subjects: 612

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 612
Study: 22508151

Group type: EXPERIMENTAL
Intervention: 57 μg/kg/day r-hGH
Number of subjects: 22

Group type: COMPARATOR
Intervention: 35 μg/kg/day r-hGH
Number of subjects: 22
Study: 19996196

Group type: EXPERIMENTAL
Intervention: High-dose pirfenidone (1,800 mg/day)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Low-dose pirfenidone (1,200 mg/day)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study: 18789113

Group type: EXPERIMENTAL
Intervention: Leukocytapheresis
Number of subjects: 0
Study: 16125959

Group type: EXPERIMENTAL
Intervention: Tranexamic acid 1g before skin incision and continuously 200mg/h
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Aprotinin 1,000,000 IU before skin incision and 250,000 IU/h
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 11898025

Group type: EXPERIMENTAL
Intervention: Somatropin (0.15 mg/kg/day divided into two equal doses via intramuscular injection)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Somatropin
Number of subjects: 24
Study: 10091821

Group type: EXPERIMENTAL
Intervention: Higher pulse pressure
Number of subjects: 6781

Group type: EXPERIMENTAL
Intervention: Higher mean arterial pressure
Number of subjects: 6781
Study: 7772081

Group type: EXPERIMENTAL
Intervention: Colestipol tablets 4 g/day
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Colestipol tablets 16 g/day
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Colestipol granules 4 g/day
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Colestipol granules 16 g/day
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 2267478

Group type: EXPERIMENTAL
Intervention: 2 h of bright light exposure in the morning
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Light restriction in the evening
Number of subjects: 20
Study: 7438772

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice daily, increased to a maximum of 400 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metoprolol (same total dosage as twice-daily regimen, administered once daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (during 4-week run-in period)
Number of subjects: 20
Study: 31910903

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg once daily
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg once daily
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Prasugrel 10 mg once daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 56

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 56
Study: 30991661

Group type: EXPERIMENTAL
Intervention: Acute aerobic exercise with moderate intensity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acute aerobic exercise with high intensity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chronic aerobic exercise with moderate intensity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chronic aerobic exercise with high intensity
Number of subjects: 60
Study: 28076358

Group type: EXPERIMENTAL
Intervention: Congregate Housing First (CHF)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Scattered Housing First (SHF)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 297
Study: 25887324

Group type: EXPERIMENTAL
Intervention: Tele-Yoga intervention (8-week duration, biweekly one-hour classes via multipoint videoconferencing)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Educational control (information leaflets mailed with one phone call a week)
Number of subjects: 15
Study: 24073411

Group type: EXPERIMENTAL
Intervention: Worksite cervical screening initiative
Number of subjects: 403

Group type: COMPARATOR
Intervention: Usual care from the existing cervical screening program
Number of subjects: 403
Study: 21544823

Group type: EXPERIMENTAL
Intervention: Chewed enteric-coated acetylsalicylic acid (ECA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intact or chewed nonenteric-coated buffered acetylsalicylic acid (NBA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chewed ECA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intact or chewed NBA
Number of subjects: 0
Study: 19124530

Group type: EXPERIMENTAL
Intervention: Dual-chamber permanent pacing with rate-drop response programming (DDD/RDR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (ODO)
Number of subjects: 34
Study: 17876251

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combination of Oxycodone and Ibuprofen
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 66
Study: 14706480

Group type: EXPERIMENTAL
Intervention: SMR training (12-15 Hz)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Beta1 training (15-18 Hz)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (non-neurofeedback)
Number of subjects: 25
Study: 11254160

Group type: EXPERIMENTAL
Intervention: Doppler velocimetry of the umbilical artery
Number of subjects: 0
Study: 9431267

Group type: EXPERIMENTAL
Intervention: 500 mg acetylsalicylic acid (ASA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No acetylsalicylic acid (ASA)
Number of subjects: 10
Study: 8497169

Group type: EXPERIMENTAL
Intervention: enalapril (10-40 mg/d)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: atenolol (25-100 mg/d)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: verapamil-retard (120-240 mg/d)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: alphametildopa (250 mg/8h to 3 g/d)
Number of subjects: 60
Study: 3580510

Group type: EXPERIMENTAL
Intervention: Oral nifedipine formulations (10 mg single dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Simulation of plasma profiles of nifedipine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Statistical methods for bioequivalence evaluation
Number of subjects: 12
Study: 31167421

Group type: EXPERIMENTAL
Intervention: Andalusian aged white wine (AWW)
Number of subjects: 38

Group type: COMPARATOR
Intervention: gin
Number of subjects: 38
Study: 28983803

Group type: EXPERIMENTAL
Intervention: Internal Astigmatism (IA)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Ocular Residual Astigmatism (ORA)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Corneal Astigmatism (ACA)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Correlation of IA and ORA with axial length
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Correlation of IA and ORA with spherical equivalent refraction
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Correlation of IA and ORA with corneal astigmatism
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Comparison of IA powers between genders
Number of subjects: 206
Study: 25480874

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (5-FU/LV or capecitabine)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 437
Study: 23323721

Group type: EXPERIMENTAL
Intervention: Medication dispensing device
Number of subjects: 96
Study: 21981853

Group type: EXPERIMENTAL
Intervention: Noninvasive repetitive transorbital alternating current stimulation (rtACS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 42
Study: 19799779

Group type: EXPERIMENTAL
Intervention: Community occupational therapy programme including 10 sessions occupational therapy at home
Number of subjects: 140

Group type: COMPARATOR
Intervention: Community occupational therapy consultation based on information material of the Alzheimer Society
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Community occupational therapy programme
Number of subjects: 140
Study: 16399302

Group type: EXPERIMENTAL
Intervention: Single aortic clamping (reduced aortic manipulation)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Multiple aortic clamping (traditional approach)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Off-pump coronary artery bypass surgery
Number of subjects: 169
Study: 15622015

Group type: EXPERIMENTAL
Intervention: PD patients with mood fluctuations
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: PD patients with anxiety fluctuations
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: PD patients with motor fluctuations
Number of subjects: 87

Group type: COMPARATOR
Intervention: Non-fluctuators
Number of subjects: 87
Study: 11528549

Group type: EXPERIMENTAL
Intervention: Study AML-BFM-93-OST
Number of subjects: 262
Study: 9780942

Group type: EXPERIMENTAL
Intervention: Combined treatment approach
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Counseling combined with different occlusal treatments
Number of subjects: 50

Group type: COMPARATOR
Intervention: Other treatments
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Awareness of stress
Number of subjects: 50
Study: 8091318

Group type: EXPERIMENTAL
Intervention: ZD2138 (350 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3377456

Group type: EXPERIMENTAL
Intervention: 0.5 g of cefodizime
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: 1 g of cefodizime
Number of subjects: 424

Group type: COMPARATOR
Intervention: 1 g of cefotaxime
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Cefodizime
Number of subjects: 424

Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 424
Study: 24626145

Group type: EXPERIMENTAL
Intervention: Automated telephony intervention
Number of subjects: 108
Study: 31754065

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally 24 hours prior to procedure and misoprostol 400 μg buccally 2 hours before procedure
Number of subjects: 49

Group type: COMPARATOR
Intervention: Osmotic dilators inserted 24 hours prior to procedure
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Mifepristone and misoprostol
Number of subjects: 49
Study: 28446028

Group type: EXPERIMENTAL
Intervention: Nutritional Supplementation Group (NSG)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Nutritional Supplementation Psychomotor Rehabilitation Program Group (NSPRG)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 79
Study: 23536236

Group type: EXPERIMENTAL
Intervention: Multidisciplinary perspectives intervention with community involvement (MPI&CI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (comparison group)
Number of subjects: 40
Study: 24284150

Group type: EXPERIMENTAL
Intervention: QIRC strategy including workshops, access to opinion leaders, intraoperative demonstrations, postoperative questionnaires, and audit and feedback.
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: QIRC strategy (experimental arm)
Number of subjects: 56
Study: 21272400

Group type: EXPERIMENTAL
Intervention: GMP diet
Number of subjects: 72

Group type: COMPARATOR
Intervention: SMP diet
Number of subjects: 72

Group type: COMPARATOR
Intervention: SSMP diet
Number of subjects: 72
Study: 19296257

Group type: EXPERIMENTAL
Intervention: Sodium phosphate (NaP)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 115
Study: 16499517

Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 1014

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 1014
Study: 15156528

Group type: EXPERIMENTAL
Intervention: n-3 PUFA (fish oil supplements) - 1.8 g of EPA and 1.2 g of DHA daily for 2 years
Number of subjects: 0
Study: 11720074

Group type: EXPERIMENTAL
Intervention: Zinc oxide/petrolatum diaper
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control diaper (identical except for absence of ZnO/Pet)
Number of subjects: 268
Study: 9386869

Group type: EXPERIMENTAL
Intervention: TOR60 (60 mg daily)
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: TOR240 (240 mg daily)
Number of subjects: 463

Group type: COMPARATOR
Intervention: TAM40 (40 mg daily)
Number of subjects: 463
Study: 8197648

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) alone
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combination of papaverine, phentolamine, and PGE1
Number of subjects: 35
Study: 3046409

Group type: EXPERIMENTAL
Intervention: Bricanyl Turbuhaler (BT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Metered Dose Inhaler (MDI) Bricanyl
Number of subjects: 9
Study: 29664899

Group type: EXPERIMENTAL
Intervention: Conditional follow-up arm
Number of subjects: 4595

Group type: COMPARATOR
Intervention: Universal follow-up arm
Number of subjects: 4595
Study: 28344102

Group type: EXPERIMENTAL
Intervention: Enzalutamide in patients with liver metastases
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Enzalutamide in patients with lung metastases only
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control (placebo) in patients with liver metastases
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control (placebo) in patients with lung metastases only
Number of subjects: 204
Study: 26282650

Group type: EXPERIMENTAL
Intervention: Obinutuzumab (1,000 mg)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Rituximab (375 mg/m2)
Number of subjects: 175
Study: 25098075

Group type: EXPERIMENTAL
Intervention: Movie-based simulation training (group B, n = 30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of movie-based simulation training and traditional verbal training (group A, n = 30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional verbal training alone (group C, n = 30)
Number of subjects: 90
Study: 21150850

Group type: EXPERIMENTAL
Intervention: Remifentanil (continuous infusion 0.25 mcg/kg · min)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fentanyl (bolus dose 2.0 mcg/kg)
Number of subjects: 50
Study: 18332291

Group type: EXPERIMENTAL
Intervention: Direct-to-patient intervention (2 mailings 2 months apart)
Number of subjects: 836

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 836
Study: 22513649

Group type: EXPERIMENTAL
Intervention: Vertebroplasty (VP)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 125
Study: 15862729

Group type: EXPERIMENTAL
Intervention: Electronic survey (e-survey)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Postal survey
Number of subjects: 202
Study: 12723391

Group type: EXPERIMENTAL
Intervention: VADO approach
Number of subjects: 95

Group type: COMPARATOR
Intervention: Usual rehabilitation practice (Control)
Number of subjects: 95
Study: 10442960

Group type: EXPERIMENTAL
Intervention: Intra-articular tenoxicam 20 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intravenous tenoxicam
Number of subjects: 88
Study: 7786822

Group type: EXPERIMENTAL
Intervention: CPT-11 administered as a 30-min i.v. infusion according to 3 different schedules: daily for 3 consecutive days every 3 weeks, weekly for 3 weeks, and once every 3 weeks.
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: CPT-11
Number of subjects: 235
Study: 2162276

Group type: EXPERIMENTAL
Intervention: Resistive loading
Number of subjects: 12
Study: 508162

Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 0
Study: 12230222

Group type: EXPERIMENTAL
Intervention: Itraconazole (50-100 mg d(-1))
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ketoconazole (200-400 mg d(-1))
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Sulfadiazine (100-150 mg kg d(-1) up to 6 g d(-1))
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study: 29199141

Group type: EXPERIMENTAL
Intervention: 50 mg amitriptyline
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: 10 mg escitalopram
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 27513932

Group type: EXPERIMENTAL
Intervention: Aerobic exercise group
Number of subjects: 116

Group type: COMPARATOR
Intervention: Reference group (lectures)
Number of subjects: 116
Study: 24395298

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg + Alcohol 0.8 g/kg (HYD + A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bilastine 80 mg + Alcohol 0.8 g/kg (B80 + A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg + Alcohol 0.8 g/kg (CET + A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bilastine 20 mg + Alcohol 0.8 g/kg (B20 + A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alcohol 0.8 g/kg alone (ALC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 22738884

Group type: EXPERIMENTAL
Intervention: Back App chair
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard backless office chair
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both chairs
Number of subjects: 12
Study: 20191662

Group type: EXPERIMENTAL
Intervention: Experimental writing tasks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control writing task
Number of subjects: 0
Study: 18549857

Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 2386

Group type: COMPARATOR
Intervention: No history of hypertension
Number of subjects: 2386

Group type: EXPERIMENTAL
Intervention: History of hypertension with baseline systolic blood pressure <140 mm Hg
Number of subjects: 2386

Group type: COMPARATOR
Intervention: No history of hypertension with baseline systolic blood pressure <140 mm Hg
Number of subjects: 2386
Study: 16902151

Group type: EXPERIMENTAL
Intervention: EBV positivity (detected by EBER-ISH)
Number of subjects: 110

Group type: COMPARATOR
Intervention: EBV negativity (detected by EBER-ISH)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Age older than 60 years
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: High LDH level
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: EBV positivity in elderly population
Number of subjects: 110
Study: 12806595

Group type: EXPERIMENTAL
Intervention: Enalapril maleate (40 mg/day) for six months
Number of subjects: 9

Group type: COMPARATOR
Intervention: Hypertensive group
Number of subjects: 9
Study: 10817768

Group type: EXPERIMENTAL
Intervention: Fast track appointment with a 6-week target waiting time
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ordinary appointment
Number of subjects: 100
Study: 8869769

Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nimodipine
Number of subjects: 50
Study: 1739794

Group type: EXPERIMENTAL
Intervention: Single high dose of vitamin A supplementation
Number of subjects: 7197
Study: 6340411

Group type: EXPERIMENTAL
Intervention: Sucrose high sodium solution (90 mEq/l)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sucrose low sodium solution (58 mEq/l)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 51